Literature DB >> 12454685

Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease.

T J Bivalacqua1, H C Champion, W J G Hellstrom.   

Abstract

Peyronie's disease is an idiopathic, localized connective tissue disorder of the penis which involves the tunica albuginea of the corpus cavernosum and the adjacent areolar space. Peyronie's disease is characterized by local changes in the collagen and elastic fiber composition of the tunica albuginea. The formation of fibrotic plaques alters penile anatomy and can cause different degrees of bending and narrowing, as well as penile pain and erectile dysfunction. Though long recognized as an important clinical entity of the male genitalia, the etiology of this disease has remained poorly understood. Until recently there have been no studies to examine the role nitric oxide (NO) and nitric oxide synthase (NOS) isoforms may play in the onset and progression of Peyronie's disease. NO is a potent biological mediator with diverse physiological and pathophysiological roles. The purpose of this review is to describe each of the NOS isoforms and their potential roles in the pathophysiology of Peyronie's disease, with particular emphasis on the regulation of endothelial and inducible NOS isoforms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454685     DOI: 10.1038/sj.ijir.3900872

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  4 in total

1.  Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application.

Authors:  Gianni Paulis; Andrea Paulis; Gennaro Romano; Davide Barletta; Andrea Fabiani
Journal:  Res Rep Urol       Date:  2017-07-20

Review 2.  Recent Pathophysiological Aspects of Peyronie's Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment-Literature Review.

Authors:  Gianni Paulis; Gennaro Romano; Luca Paulis; Davide Barletta
Journal:  Adv Urol       Date:  2017-07-04

3.  Endothelial nitric oxide synthase Glu298Asp gene polymorphism in the cases of idiopathic thrombocytopenic purpura.

Authors:  Saadet Akarsu; Feyzullah Necati Arslan; Deniz Erol
Journal:  Blood Res       Date:  2022-08-03

4.  Clinical use of hyaluronic acid in andrology: A review.

Authors:  Alessandro Zucchi; Fabrizio Ildefonso Scroppo; Paolo Capogrosso; Andrea Salonia; Jacopo Duante; Vittorio Bini; Giovanni Liguori; Riccardo Bartoletti
Journal:  Andrology       Date:  2021-08-02       Impact factor: 4.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.